Showing results (281-290 of 583) with videos related to
Sort By:
Pageof 59
European Journal of Medicinal Chemistry|September 28, 2011
Discovery of a new class of bicyclic substituted hydroxyphenylmethanones as 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2) inhibitors for the treatment of osteoporosisMarie Wetzel, Emanuele M Gargano, Stefan Hinsberger, et al.Journal of Medicinal Chemistry|February 16, 1996
Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 17G A Wächter, R W Hartmann, T Sergejew, et al.Journal of Medicinal Chemistry|July 14, 2012
Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndromeLina Yin, Simon Lucas, Frauke Maurer, et al.Journal of Neurology|December 2, 2010
Congenital prosopagnosia: multistage anatomical and functional deficits in face processing circuitryV Dinkelacker, M Grüter, P Klaver, et al.Blut|April 1, 1981
High-dose nitrogen mustard (HN2) with autologous nonfrozen bone marrow transplantation in advanced malignant melanoma. A phase I trialD W Hartmann, W A Robinson, N J Morton, et al.Archiv Der Pharmazie|July 9, 2004
Synthesis and evaluation of a dimer of 2-(4-pyridylmethyl)-1-indanone as a novel nonsteroidal aromatase inhibitorRanju Gupta, Dharam Paul Jindal, Birinder Jit, et al.Experimental Cell Research|December 10, 1999
IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cellsS G Gray, T Yakovleva, W Hartmann, et al.Journal of Medicinal Chemistry|December 4, 2008
In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivativesSimon Lucas, Ralf Heim, Christina Ries, et al.Disease Management : DM|October 28, 2003
Care management for persistent pain: an introductionChristine W Hartmann, Neil I Goldfarb, Susan S Kim, et al.Archiv Der Pharmazie|July 12, 2008
Structural modifications of salicylates: inhibitors of human CD81-receptor HCV-E2 interactionMarcel Holzer, Sigrid Ziegler, Alexander Neugebauer, et al.Pageof 59